Clinical Trials Logo

Ventricular Premature Complexes clinical trials

View clinical trials related to Ventricular Premature Complexes.

Filter by:

NCT ID: NCT05373862 Completed - Clinical trials for Ventricular Tachycardia

A Study Assessing Arrhythmia Mapping With a Globe-Shaped, High-Density, Multi-Electrode Mapping Catheter

COSMOS
Start date: July 29, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the performance and safety for the use of the investigational catheter for intracardiac mapping in the atria and ventricles.

NCT ID: NCT05341544 Recruiting - Clinical trials for Premature Ventricular Contraction

Non-invasive Vagal Stimulation for Frequent Premature Ventricular Complexes

(NoVa-PVC)
Start date: August 22, 2022
Phase: N/A
Study type: Interventional

A prospective sham-controlled randomized clinical trial to assess the effect of low-level tragus stimulation (LLTS) in patients with frequent premature ventricular complexes (PVCs)

NCT ID: NCT05167058 Completed - Atrial Fibrillation Clinical Trials

Electrocardiographic Diagnostic Performance of the Apple Watch Augmented With an Artificial Intelligence Algorithm

Start date: April 21, 2022
Phase:
Study type: Observational

The SWAF study will compare the performance of a smartwatch combined with Cardiologs Platform algorithm in the detection of Atrial Fibrillation and other arrhythmias with that measured on a manually read 12-lead ECG in subjects hospitalized for cardioversion or AF ablation.

NCT ID: NCT05158751 Not yet recruiting - Myocarditis Clinical Trials

Myocarditis Causing Premature Ventricular Contractions:Insights From the MAVERIC Registry

MAVERIC
Start date: January 2023
Phase:
Study type: Observational

To assess potential link between unrecognized myocardial inflammation (myocarditis) and premature ventricular contractions (PVCs) associated with and without reduced Left ventricular ejection fraction (LVEF) through comprehensive diagnostic work up.

NCT ID: NCT05087238 Completed - Clinical trials for Ventricular Premature Complexes

CBT for Premature Ventricular Contractions

PVC-CBT
Start date: January 14, 2021
Phase: N/A
Study type: Interventional

The purpose of the present interdisciplinary research program is to develop and evaluate a disease-specific cognitive behavior therapy (CBT) protocol to increase quality of life (QoL) and reduce symptom burden in patients with Premature Ventricular Contractions (PVC).

NCT ID: NCT05078125 Not yet recruiting - Clinical trials for Premature Ventricular Complex

Electrocardiographic and Cardiac Magnetic Resonance Predictors of Ventricular Arrhythmias in Cardiomyopathic Patients

Start date: April 1, 2022
Phase:
Study type: Observational

This study aims to assess ECG changes for predicting ventricular arrhythmia in cardiomyopathic patients

NCT ID: NCT05061498 Recruiting - Catheter Ablation Clinical Trials

Impact of Pacing Output and Cycle Length on QRS Morphology

Start date: December 1, 2021
Phase: N/A
Study type: Interventional

Current recommendations for pacemapping are based on expert opinion and animals models. Present study sought to evaluate the influence of different parameters of pacemapping on QRS morphology. Pacemapping is performed with different cycle length (fixed burst vs. coupling interval) and stimulation output (maximum output vs. threshold) and resulting QRS complexes are compared to clinical PVC and the standard of care to determine the optimal parameter setting in pacemapping.

NCT ID: NCT05008250 Completed - Clinical trials for Premature Ventricular Contraction

Efficacy and Safety of Metoprolol Tartrate Tablets Combined With Chinese Traditional Medicine on Premature Ventricular Complex.

Start date: January 2014
Phase: Phase 4
Study type: Interventional

Objective: investigators investigated the effects of metoprolol tartrate plus Tongmai Yangxin Pill on premature ventricular complexes and cardiac function in patients with premature ventricular complex. Methods: In total, 584 participants with premature ventricular complex will be randomly assigned (at a 1:1 ratio) into two groups: study group (metoprolol tartrate [25 mg twice per day, orally] plus Tongmai Yangxin Pill [40 pills twice per day, orally]) and control group (metoprolol tartrate [25 mg twice per day, orally] plus placebo [40 simulated pills twice per day, orally]). The total treatment period is 8 weeks. Efficacy endpoints and safety assessment: Primary efficacy endpoints are as follows: change in 24-h number of PVCs after treatment and effective rate of 24-h number of PVCs after treatment. Secondary efficacy endpoints are as follows: change in New York Heart Association classification; total effective rate of comprehensive effect; change in high-sensitivity C-reactive protein level; and change in echocardiography parameters (i.e., left ventricular ejection fraction, left ventricular end diastolic dimension, E/A, cardiac index, cardiac output, and stroke volume).

NCT ID: NCT04990089 Not yet recruiting - Clinical trials for Ventricular Tachycardia

VIVO European Observational Registry

Start date: September 1, 2021
Phase:
Study type: Observational [Patient Registry]

A multi-center, observational registry conducted in Europe and the UK to prospectively review VIVO in a clinical setting in 125 patients.

NCT ID: NCT04983797 Completed - Clinical trials for Paroxysmal Atrial Fibrillation

A Study Assessing Arrhythmia Mapping With the Multi-Electrode OPTRELLâ„¢ Mapping Catheter

OPTIMUM
Start date: August 25, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the performance and safety for the use of the OPTRELL Catheter for intracardiac mapping in the atria and ventricles.